Atara Biotherapeutics Inc (ATRA)
16.35
+2.19
(+15.47%)
USD |
NASDAQ |
Jan 03, 16:00
16.00
-0.35
(-2.14%)
After-Hours: 05:08
Atara Biotherapeutics SG&A Expense (Quarterly): 10.42M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.975M |
| Jaguar Health Inc | 5.786M |
| Corvus Pharmaceuticals Inc | 2.033M |
| Clearside Biomedical Inc | 2.844M |
| SpringWorks Therapeutics Inc | 61.60M |